Solventum SOLV
NYSE SOLV
$87.88 +0.12 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Solventum (SOLV) Gains from Sales and Divestitures (2025)

Updated

Solventum (SOLV) reported Gains from Sales and Divestitures of $31 million for Q4 2025, down 98.0% from the prior quarter.

Analysis

Solventum (SOLV) Gains from Sales and Divestitures (2025) Analysis & Trends

For FY2025, Solventum posted Gains from Sales and Divestitures of $1.55 billion.

  • By year, Gains from Sales and Divestitures came in at $56 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Solventum 14.95 Bn 11.47 Bn 1.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 31.00 Mn
Sep 30, 2025 1.52 Bn
API Access

Solventum Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SOLV&period=max&api_key=YOUR_API_KEY